Vanderbilt University Medical Center
Matthew Stier
The purpose of this study is to understand how cells of the immune system use the common sugar glucose to fuel energy production and as a building block within the cell. Investigators will intravenously infuse a non-radioactive glucose tracer into participants over a few hours and collect immune cells from the blood to track uptake and usage of this glucose within these immune cells.
Glucose
Metabolism
Isotope Labeling
Immune System and Related Disorders
13C6-Glucose
NA
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 12 participants |
| Masking : | NONE |
| Primary Purpose : | BASIC_SCIENCE |
| Official Title : | Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells |
| Actual Study Start Date : | 2025-10-01 |
| Estimated Primary Completion Date : | 2027-06-30 |
| Estimated Study Completion Date : | 2027-06-30 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212